2021 Q3 Form 10-Q Financial Statement

#000156459021056298 Filed on November 10, 2021

View on sec.gov

Income Statement

Concept 2021 Q3 2020 Q3
Revenue $15.98M $12.98M
YoY Change 23.18% -13.14%
Cost Of Revenue $10.47M $8.074M
YoY Change 29.64% -18.51%
Gross Profit $5.517M $4.902M
YoY Change 12.55% -2.55%
Gross Profit Margin 34.51% 37.77%
Selling, General & Admin $3.491M $1.817M
YoY Change 92.06% -17.01%
% of Gross Profit 63.28% 37.08%
Research & Development $999.7K $1.001M
YoY Change -0.16% -3.39%
% of Gross Profit 18.12% 20.43%
Depreciation & Amortization $396.2K $410.0K
YoY Change -3.37% 17.14%
% of Gross Profit 7.18% 8.36%
Operating Expenses $4.490M $3.922M
YoY Change 14.49% -14.93%
Operating Profit $1.026M $979.4K
YoY Change 4.78% 133.45%
Interest Expense -$36.21K $174.2K
YoY Change -120.79% 233.84%
% of Operating Profit -3.53% 17.79%
Other Income/Expense, Net -$9.690K -$63.90K
YoY Change -84.84% -186.01%
Pretax Income $980.4K $915.5K
YoY Change 7.08% 85.39%
Income Tax -$320.00 $57.75K
% Of Pretax Income -0.03% 6.31%
Net Earnings $980.7K $857.8K
YoY Change 14.33% 57.42%
Net Earnings / Revenue 6.14% 6.61%
Basic Earnings Per Share $0.05 $0.05
Diluted Earnings Per Share $49.13K $0.05
COMMON SHARES
Basic Shares Outstanding 18.64M 16.59M
Diluted Shares Outstanding 19.96M 17.02M

Balance Sheet

Concept 2021 Q3 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $18.49M $5.520M
YoY Change 234.95% 30.5%
Cash & Equivalents $3.955M $5.520M
Short-Term Investments $14.53M
Other Short-Term Assets $1.122M $720.0K
YoY Change 55.82% -12.2%
Inventory $14.36M $10.00M
Prepaid Expenses
Receivables $5.808M $9.744M
Other Receivables $0.00 $0.00
Total Short-Term Assets $39.78M $25.98M
YoY Change 53.1% 15.59%
LONG-TERM ASSETS
Property, Plant & Equipment $3.091M $3.568M
YoY Change -13.36% 5.86%
Goodwill $7.121M
YoY Change
Intangibles $826.2K
YoY Change
Long-Term Investments
YoY Change
Other Assets $3.640M $4.020M
YoY Change -9.45% 29.68%
Total Long-Term Assets $14.02M $15.54M
YoY Change -9.74% 2.75%
TOTAL ASSETS
Total Short-Term Assets $39.78M $25.98M
Total Long-Term Assets $14.02M $15.54M
Total Assets $53.80M $41.52M
YoY Change 29.58% 10.42%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.846M $3.680M
YoY Change 4.51% 2.51%
Accrued Expenses $2.270M $1.910M
YoY Change 18.85% -26.54%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due $4.327M $3.431M
YoY Change 26.11% 55.52%
Total Short-Term Liabilities $11.60M $10.52M
YoY Change 10.26% 10.0%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $2.454M
YoY Change -100.0% 306.5%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $2.454M
YoY Change -100.0% 306.5%
TOTAL LIABILITIES
Total Short-Term Liabilities $11.60M $10.52M
Total Long-Term Liabilities $0.00 $2.454M
Total Liabilities $11.60M $12.97M
YoY Change -10.6% 27.78%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $42.21M $28.60M
YoY Change
Total Liabilities & Shareholders Equity $53.80M $41.52M
YoY Change 29.58% 10.43%

Cashflow Statement

Concept 2021 Q3 2020 Q3
OPERATING ACTIVITIES
Net Income $980.7K $857.8K
YoY Change 14.33% 57.42%
Depreciation, Depletion And Amortization $396.2K $410.0K
YoY Change -3.37% 17.14%
Cash From Operating Activities $508.8K $1.550M
YoY Change -67.18% -217.42%
INVESTING ACTIVITIES
Capital Expenditures -$113.5K -$240.0K
YoY Change -52.73% -65.71%
Acquisitions
YoY Change
Other Investing Activities -$8.380K $0.00
YoY Change
Cash From Investing Activities -$121.8K -$250.0K
YoY Change -51.27% -64.29%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -400.1K -490.0K
YoY Change -18.34% -136.57%
NET CHANGE
Cash From Operating Activities 508.8K 1.550M
Cash From Investing Activities -121.8K -250.0K
Cash From Financing Activities -400.1K -490.0K
Net Change In Cash -13.19K 810.0K
YoY Change -101.63% -219.12%
FREE CASH FLOW
Cash From Operating Activities $508.8K $1.550M
Capital Expenditures -$113.5K -$240.0K
Free Cash Flow $622.2K $1.790M
YoY Change -65.24% -388.71%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
18666022
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
15984293
CY2021Q3 oss Nonoperating Interest Income
NonoperatingInterestIncome
92105
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
980696
CY2021Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1458
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
29285833
oss Stock Issued During Period Value Exercise Of Stock Options Restricted Stock Units And Warrants
StockIssuedDuringPeriodValueExerciseOfStockOptionsRestrictedStockUnitsAndWarrants
301520
oss Stock Issued During Period New Issues Issuance Cost
StockIssuedDuringPeriodNewIssuesIssuanceCost
811327
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
9188673
us-gaap Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
-114143
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-143086
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
601
us-gaap Net Income Loss
NetIncomeLoss
1738320
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
41161448
CY2021Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
399148
CY2021Q3 oss Stock Issued During Period Value Exercise Of Stock Options Restricted Stock Units And Warrants
StockIssuedDuringPeriodValueExerciseOfStockOptionsRestrictedStockUnitsAndWarrants
61173
CY2021Q3 us-gaap Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
-457507
CY2021Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
60813
CY2021Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1458
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
980696
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
42207229
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
28766162
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
293139
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
64467
oss Return Of Capital Upon Dissolution Of Joint Venture
ReturnOfCapitalUponDissolutionOfJointVenture
-500
us-gaap Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
-670599
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
11875
us-gaap Net Income Loss
NetIncomeLoss
-1108194
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
27356350
CY2020Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
210280
CY2020Q3 oss Stock Issued During Period Value Exercise Of Stock Options Restricted Stock Units And Warrants
StockIssuedDuringPeriodValueExerciseOfStockOptionsRestrictedStockUnitsAndWarrants
60000
CY2020Q3 us-gaap Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
-13847
CY2020Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
130280
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
857790
CY2020Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
28600853
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
520035
us-gaap Depreciation
Depreciation
688727
oss Gain On Forgiveness Of Paycheck Protection Program Loan And Interest
GainOnForgivenessOfPaycheckProtectionProgramLoanAndInterest
1514354
oss Investment In Short Term Investment Grade Securities
InvestmentInShortTermInvestmentGradeSecurities
14532025
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
664385
oss Proceeds From Exercise Of Stock Options And Warrants
ProceedsFromExerciseOfStockOptionsAndWarrants
124467
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
2307818
us-gaap Repayments Of Medium Term Notes
RepaymentsOfMediumTermNotes
1852277
us-gaap Repayments Of Medium Term Notes
RepaymentsOfMediumTermNotes
131792
oss Repayments Of Senior Secured Convertible Note
RepaymentsOfSeniorSecuredConvertibleNote
409090
oss Proceeds From Paycheck Protection Program Note Payable
ProceedsFromPaycheckProtectionProgramNotePayable
1499360
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3955215
CY2021Q3 us-gaap Short Term Investments
ShortTermInvestments
14534084
us-gaap Operating Income Loss
OperatingIncomeLoss
1817960
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3297125
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-424281
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-250173
us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;color:#212529;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="text-decoration:underline;">Use of Estimates</span></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:3.7%;color:#212529;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent liabilities at the date of the condensed consolidated financial statements, and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from these estimates and assumptions.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.7%;color:#212529;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On an ongoing basis, our management evaluates these estimates and assumptions, including those related to determination of standalone selling prices of our products and services, allowance for doubtful account and sales reserves, income tax valuations, stock-based compensation, goodwill, intangible assets and inventory valuations and recoverability. We base our estimates on historical data and experience, as well as various other factors that our management believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities.</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.7%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.7%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of September 30, 2021, we had $3,604,607 in net deferred tax assets (“DTAs”). These DTAs include approximately $5.3 million related to net operating loss carryforwards that can be used to offset taxable income in future periods and reduce our income taxes payable in those future periods.  At this time, we consider it more likely than not that we will have sufficient taxable income in the future that will allow us to realize these DTAs. However, it is possible <span style="color:#000000;">that economic conditions may </span>decrease the likelihood that we will have sufficient taxable income in the future. Therefore, unless we are able to generate sufficient taxable income from our operations, a substantial valuation allowance to reduce our U.S. DTAs may be required, which would materially increase our expenses in the period the allowance is recognized and materially adversely affect our results of operations and statement of financial condition. </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.7%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:3.7%;color:#212529;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">On March 11, 2021, Congress passed, and the President signed into law, the American Rescue Plan Act, 2021 (the “ARP”), which includes certain business tax provisions.</span><span style="font-size:9pt;color:#000000;"> </span><span style="Background-color:#FFFFFF;">At this point, we do not believe that these changes will have a material impact on our income tax provision for 2021. We will continue to evaluate the impact of new legislation on our financial position, results of operations, and cash flows.</span></p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:3.7%;color:#212529;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Due to the COVID-19 pandemic, there has been uncertainty and disruption in the global economy and financial markets. We are not aware of any specific event or circumstance that would require an update to our estimates or assumptions or a revision of the carrying value of our assets or liabilities as of the date of this Quarterly Report on Form 10-Q. These estimates and assumptions may change as new events occur and additional information is obtained. As a result, actual results could differ materially from these estimates and assumptions.</p>
CY2021Q3 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
3604607
CY2021Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
5300000
us-gaap Operating Lease Payments
OperatingLeasePayments
1256000
CY2021Q3 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
5835675
CY2020Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
7491503
CY2021Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
27491
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
33120
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5808184
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
7458383
CY2021Q3 us-gaap Inventory Net
InventoryNet
14361034
CY2020Q4 us-gaap Inventory Net
InventoryNet
9647504
CY2021Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3538793
CY2021Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3368237
CY2021Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
170556
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
63231
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
42154
CY2021Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
170556
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
520035
CY2021Q3 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
1147907
CY2020Q4 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
932988
CY2021Q3 oss Contract With Customer Liability And Customer Deposits
ContractWithCustomerLiabilityAndCustomerDeposits
908828
CY2020Q4 oss Contract With Customer Liability And Customer Deposits
ContractWithCustomerLiabilityAndCustomerDeposits
1096672
CY2021Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
500500
CY2020Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
425636
CY2021Q3 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
263144
CY2020Q4 us-gaap Deferred Rent Credit Current
DeferredRentCreditCurrent
312909
CY2021Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
621712
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
713239
CY2021Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
3442091
CY2020Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
3481444
CY2021Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
4327455
CY2021Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
4327455
CY2021Q3 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
9961
CY2021Q3 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
10501
CY2021Q3 oss Long Term Debt Current Net Liability Portion
LongTermDebtCurrentNetLiabilityPortion
4306993
CY2021Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
4327455
CY2021Q3 oss Long Term Debt Maturities Repayments Of Principal In Next Twelve Months Discount
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonthsDiscount
20462
CY2021Q3 us-gaap Long Term Debt
LongTermDebt
4327455
CY2021Q3 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
20462
CY2021Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
4327455
CY2021Q3 oss Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Current Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsCurrentNet
20462
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2021Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
15678
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P0Y11M8D
us-gaap Share Based Compensation
ShareBasedCompensation
1302878
us-gaap Share Based Compensation
ShareBasedCompensation
503419
CY2021Q3 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
162745
CY2020Q3 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
162262
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
614996
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
528418
CY2020Q3 oss Number Of Customers More Than Ten Percentage Of Revenue
NumberOfCustomersMoreThanTenPercentageOfRevenue
2
oss Number Of Customers More Than Ten Percentage Of Revenue
NumberOfCustomersMoreThanTenPercentageOfRevenue
2
CY2021Q3 oss Number Of Customers More Than Ten Percentage Of Net Trade Accounts Receivable
NumberOfCustomersMoreThanTenPercentageOfNetTradeAccountsReceivable
1
CY2021Q3 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
417
CY2020Q3 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
17156
oss Unused Remaining Funding Commitments Expiration Date
UnusedRemainingFundingCommitmentsExpirationDate
2020-04-01
CY2020Q3 oss Additional Funding Commitments Received
AdditionalFundingCommitmentsReceived
0
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
980696
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
857790
CY2021Q3 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
18636337
CY2020Q3 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
16585773
CY2021Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1326933
CY2020Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
432841
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17018614
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19466023
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.15
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.14
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2

Files In Submission

Name View Source Status
0001564590-21-056298-index-headers.html Edgar Link pending
0001564590-21-056298-index.html Edgar Link pending
0001564590-21-056298.txt Edgar Link pending
0001564590-21-056298-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
oss-10q_20210930.htm Edgar Link pending
oss-10q_20210930_htm.xml Edgar Link completed
oss-20210930.xsd Edgar Link pending
oss-20210930_cal.xml Edgar Link unprocessable
oss-20210930_def.xml Edgar Link unprocessable
oss-20210930_lab.xml Edgar Link unprocessable
oss-20210930_pre.xml Edgar Link unprocessable
oss-ex311_8.htm Edgar Link pending
oss-ex312_10.htm Edgar Link pending
oss-ex321_7.htm Edgar Link pending
oss-ex322_6.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending